Philip Morris Gets FDA MRTP Renewal for IQOS

FDA reauthorizes MRTP status for PMI's IQOS 2.4, IQOS 3.0 devices and three HEETS variants in the U.S.
Renewal lets PMI continue sharing reduced‑exposure information with U.S. adults 21+ and supports public‑health promotion.
PMI reports smoke‑free products generated 41.5% of FY2025 net revenue and serve over 43 million adult consumers globally.
CEO Stacey Kennedy highlighted the scientific basis of IQOS and PMI’s $16 billion investment since 2008 to end cigarette sales.